Physical activity or food intake prior to testing did not affect the reproducibility of GH secretion elicited by GH releasing hormone plus GH‐releasing hexapeptide in normal adult subjects

objective Growth hormone deficiency (GHD) in adults is a defined syndrome of which the adverse effects on different areas of body function are reversed under replacement therapy with GH. The diagnosis of GHD is controversial in adults, relying on the GH secretion elicited by the so‐called provocative tests of GH reserve. Most of the tests in use, including the widely employed insulin tolerance test, have been shown to be blunted after daily activities, such as mild exercise, heat or food intake, which makes stringent testing conditions mandatory in order to assure reproducibility. The combined administration of GH releasing hormone (GHRH) and GH‐releasing hexapeptide (GHRP‐6) is a very effective test for the diagnosis of GH deficiency in adults. In the present study, the perturbatory action of mild physical activity and food intake on the reproducibility of this combined test was assessed.

[1]  F. Casanueva,et al.  GH-releasing hormone and GH-releasing peptide-6 for diagnostic testing in GH-deficient adults , 2000, The Lancet.

[2]  M. Nakazato,et al.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach , 1999, Nature.

[3]  E. Arvat,et al.  Low dose hexarelin and growth hormone (GH)-releasing hormone as a diagnostic tool for the diagnosis of GH deficiency in adults: comparison with insulin-induced hypoglycemia test. , 1999, The Journal of clinical endocrinology and metabolism.

[4]  D. Cook Adult growth hormone deficiency syndrome: a personal approach to diagnosis, treatment and monitoring. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[5]  H. C. Hoeck,et al.  Differences in reproducibility and peak growth hormone responses to repeated testing with various stimulators in healthy adults. , 1999, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[6]  F. Casanueva,et al.  Growth Hormone Secretagogues: Physiological Role and Clinical Utility , 1999, Trends in Endocrinology & Metabolism.

[7]  H. Orskov,et al.  GH stimulation tests: evaluation of GH responses to heat test versus insulin-tolerance test. , 1998, European journal of endocrinology.

[8]  B. Brennan,et al.  The diagnosis of growth hormone deficiency in children and adults. , 1998, Endocrine reviews.

[9]  E. Ghigo,et al.  Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency. , 1998, The Journal of clinical endocrinology and metabolism.

[10]  Fisker,et al.  L‐Arginine and insulin‐tolerance tests in the diagnosis of adult growth hormone deficiency: influence of confounding factors , 1998, Clinical endocrinology.

[11]  H. C. Hoeck,et al.  Reproducibility of Growth Hormone and Cortisol Responses to the Insulin Tolerance Test and the Short ACTH Test in Normal Adults , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[12]  R. Rosenfeld Is growth hormone deficiency a viable diagnosis? , 1997, The Journal of clinical endocrinology and metabolism.

[13]  E. Ghigo,et al.  The diagnosis of growth hormone deficiency in adults. , 1997, The Journal of clinical endocrinology and metabolism.

[14]  S. Lamberts,et al.  Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. Adult Growth Hormone Deficiency Study Group. , 1997, The Journal of clinical endocrinology and metabolism.

[15]  E. Arvat,et al.  Reproducibility of the growth hormone response to stimulation with growth hormone-releasing hormone plus arginine during lifespan. , 1996, European journal of endocrinology.

[16]  F. Dammacco,et al.  Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. , 1996, The Journal of clinical endocrinology and metabolism.

[17]  F. Casanueva Diagnosis of growth hormone deficiency in adulthood. , 1996, European journal of endocrinology.

[18]  S. Shalet,et al.  Beyond the somatopause: growth hormone deficiency in adults over the age of 60 years. , 1996, The Journal of clinical endocrinology and metabolism.

[19]  H. C. Hoeck,et al.  Test of growth hormone secretion in adults: poor reproducibility of the insulin tolerance test. , 1995, European journal of endocrinology.

[20]  C. Diéguez,et al.  Growth hormone (GH) responses to the combined administration of GH-releasing hormone plus GH-releasing peptide 6 in adults with GH deficiency. , 1995, European journal of endocrinology.

[21]  F. Casanueva,et al.  Influence of metabolic substrates and obesity on growth hormone secretion , 1995, Trends in Endocrinology & Metabolism.

[22]  N. Skakkebaek,et al.  Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. , 1995, European journal of endocrinology.

[23]  H. de Boer,et al.  Clinical aspects of growth hormone deficiency in adults. , 1995, Endocrine reviews.

[24]  S. Shalet,et al.  The severity of growth hormone deficiency in adults with pituitary disease is related to the degree of hypopituitarism , 1994, Clinical endocrinology.

[25]  P. Vankrunkelsven,et al.  Salcatonin and gynaecomastia , 1994, The Lancet.

[26]  A. Grossman,et al.  An audit of the insulin tolerance test in adult subjects in an acute investigation unit over one year , 1994, Clinical endocrinology.

[27]  A. O’Sullivan,et al.  Diagnosis of growth-hormone deficiency in adults , 1994, The Lancet.

[28]  L. Saccá,et al.  Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency. , 1993, The Journal of clinical endocrinology and metabolism.

[29]  T. Jones,et al.  Gender influences counterregulatory hormone responses to hypoglycemia. , 1993, Metabolism: clinical and experimental.

[30]  R. Whitehouse,et al.  Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. , 1993, The Journal of clinical endocrinology and metabolism.

[31]  C. Billington,et al.  Intrasubject reproducibility of growth hormone-releasing hormone-stimulated growth hormone in older women, older men, and younger men , 1993, Biological Psychiatry.

[32]  L. Lönn,et al.  Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. , 1993, The Journal of clinical endocrinology and metabolism.

[33]  T. Badger,et al.  On the actions of the growth hormone-releasing hexapeptide, GHRP. , 1991, Endocrinology.

[34]  B. Bengtsson,et al.  Premature mortality due to cardiovascular disease in hypopituitarism , 1990, The Lancet.

[35]  P. Sönksen,et al.  The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. , 1989, The New England journal of medicine.

[36]  N. Skakkebaek,et al.  BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS , 1989, The Lancet.

[37]  B. Sherman,et al.  Variability in the quantitation of circulating growth hormone using commercial immunoassays. , 1989, The Journal of clinical endocrinology and metabolism.

[38]  J. Landon,et al.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin. I. In control subjects. , 1966, The Journal of clinical investigation.

[39]  V. Wynn,et al.  The plasma sugar, free fatty acid, cortisol, and growth hormone response to insulin, and the comparison of this procedure with other tests of pituitary and adrenal function. II. In patients with hypothalamic or pituitary dysfunction or anorexia nervosa. , 1966, The Journal of clinical investigation.

[40]  A. Frantz,et al.  Effects of Estrogen and Sex Difference on Secretion of Human Growth Hormone1 , 1965 .